Skip to main content
Clinical Trials/NCT06335823
NCT06335823CompletedNot Applicable

Randomized, Placebo-Controlled Study on the Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology

University Hospitals Cleveland Medical Center1 site in 1 country60 target enrollmentStarted: June 5, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Pain During IUD Insertion as Measured by the VAS Score

Study Overview

Brief Summary

Pain with intrauterine device (IUD) insertion is very common and there are few options for patients to help reduce this pain. Transcutaneous electric nerve stimulators (TENS) are a non-invasive procedure that may help reduce the pain with IUD insertions. The investigators hope that the information gleaned from this study will result in pain control options for future patients who desire an IUD placement.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 18-45 years old
  • •Individuals with a cervix and uterus
  • •Seeking intrauterine device (IUD) placement for contraception or management of abnormal uterine bleeding
  • •Meet medical eligibility for IUD placement
  • •Ability to consent in English
  • •Ability to use the visual analogue scale (VAS)

Exclusion Criteria

  • •Contraindications to IUD placement
  • •Use of analgesics within the last 4 hours prior to IUD placement
  • •Presence of a pacemaker

Arms & Interventions

Active TENS unit

Experimental

All patients will have the TENS unit applied: 2 pads from channel 1 will be at T10-L1 and the second set of pads will be from S2-S4; 5 minutes prior to the start of the procedure. Patients in this arm will have the TENS unit turned on to a 80 hz preset frequency with 100 mA as the pulse width.

Intervention: Transcutaneous electrical nerve stimulation (TENS) (Device)

Non-active TENS unit

Placebo Comparator

All patients will have the TENS unit applied: 2 pads from channel 1 will be at T10-L1 and the second set of pads will be from S2-S4; 5 minutes prior to the start of the procedure. Patients will not have the TENS unit turned on.

Intervention: Placebo Transcutaneous electrical nerve stimulation (TENS) (Device)

Outcomes

Primary Outcomes

Pain During IUD Insertion as Measured by the VAS Score

Time Frame: IUD placement/introducer removal up to 5 minute

The VAS score is a score of 0-10 with 0 being no pain and 10 being the worse pain imaginable

Secondary Outcomes

  • Pain During IUD Insertion as Measured by the VAS Score(speculum placement up to 1 minute)
  • Pain During IUD Insertion as Measured by the VAS Score(tenaculum placement up to 1 minute)
  • Pain During IUD Insertion as Measured by the VAS Score(sound insertion up to 5 minute)
  • Pain Post IUD Insertion as Measured by the VAS Score(5 minute post IUD insertion)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor
Principal Investigator

Jean Marino

APRN-CNP

University Hospitals Cleveland Medical Center

Study Sites (1)

Loading locations...

Similar Trials